TruScreen Group Ltd. (AU:TRU) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
TruScreen Group Limited, a developer of AI-enabled cervical screening devices, has announced its Annual Shareholders’ Meeting for September 3, 2024, and is currently accepting director nominations until August 19. The TruScreen Ultra device, used for real-time cervical cancer screening, has been widely recognized and adopted, with over 200,000 examinations conducted in the 2024 financial year and installations in multiple countries.
For further insights into AU:TRU stock, check out TipRanks’ Stock Analysis page.

